Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
1.
Rev. Soc. Bras. Med. Trop ; 46(6): 791-794, Nov-Dec/2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-698059

RESUMEN

Human brucellosis is an occupational disease affecting workers in slaughterhouses, butcher shops and the milk and dairy product industry as well as individuals who work in clinical or research laboratories. We report the first outbreak of a Brucella abortus infection in a Brazilian laboratory and compare the data obtained with reports available in the literature. Exposure was a result of damage to a biological safety cabinet and failure of the unidirectional airflow ventilation system. An epidemiological investigation identified 3 seroconverted individuals, 1 of whom had clinical manifestations and laboratory results compatible with infection at the time of exposure (n=11; attack rate=9.1%).


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Adulto Joven , Accidentes de Trabajo , Brucella abortus/inmunología , Brucelosis/epidemiología , Infección de Laboratorio/epidemiología , Anticuerpos Antibacterianos/sangre , Brasil/epidemiología , Brucelosis/diagnóstico , Brucelosis/inmunología , Brotes de Enfermedades , Infección de Laboratorio/diagnóstico , Infección de Laboratorio/inmunología , Personal de Laboratorio Clínico
2.
Rev Soc Bras Med Trop ; 46(6): 791-4, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24474027

RESUMEN

Human brucellosis is an occupational disease affecting workers in slaughterhouses, butcher shops and the milk and dairy product industry as well as individuals who work in clinical or research laboratories. We report the first outbreak of a Brucella abortus infection in a Brazilian laboratory and compare the data obtained with reports available in the literature. Exposure was a result of damage to a biological safety cabinet and failure of the unidirectional airflow ventilation system. An epidemiological investigation identified 3 seroconverted individuals, 1 of whom had clinical manifestations and laboratory results compatible with infection at the time of exposure (n=11; attack rate=9.1%).


Asunto(s)
Accidentes de Trabajo , Brucella abortus/inmunología , Brucelosis/epidemiología , Infección de Laboratorio/epidemiología , Adulto , Anticuerpos Antibacterianos/sangre , Brasil/epidemiología , Brucelosis/diagnóstico , Brucelosis/inmunología , Brotes de Enfermedades , Femenino , Humanos , Infección de Laboratorio/diagnóstico , Infección de Laboratorio/inmunología , Masculino , Personal de Laboratorio Clínico , Adulto Joven
3.
J Infect Dis ; 176(4): 859-66, 1997 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9333142

RESUMEN

Hepatitis C virus (HCV) is a common infection worldwide, and in most persons, it leads to persistent viremia and liver damage. Efforts to identify the correlates of protective immunity are hampered by this high rate of persistent infection in both infected humans and the only animal model, the chimpanzee. Peripheral blood mononuclear cells from seronegative persons were stimulated with synthetic peptides that represent epitopes recognized by HCV-specific cytotoxic T lymphocytes (CTL) after natural infection. In addition, CD4+ proliferative responses to recombinant HCV proteins were examined in these same persons. CTL responses directed against a peptide epitope of HCV and proliferative responses in 2 HCV-seronegative persons with possible occupational exposure to HCV were found. These otherwise healthy persons were not viremic, suggesting that they may have recovered from acute HCV infection. Characterization of virus-specific immune responses in exposed but seronegative persons may provide important clues as to the nature of protective immunity in HCV.


Asunto(s)
Hepatitis C/inmunología , Linfocitos T Citotóxicos/inmunología , Linfocitos T Colaboradores-Inductores/inmunología , Candida/inmunología , División Celular , Pruebas Inmunológicas de Citotoxicidad , Epítopos/inmunología , Antígenos de la Hepatitis C/inmunología , Prueba de Histocompatibilidad , Humanos , Infección de Laboratorio/inmunología , Leucocitos Mononucleares/inmunología , Péptidos/síntesis química , Péptidos/inmunología , Proteínas Recombinantes/inmunología , Tuberculina , Células Tumorales Cultivadas , Proteínas Virales/genética , Proteínas Virales/inmunología
5.
Rev. Inst. Med. Trop. Säo Paulo ; 35(6): 521-5, nov.-dez. 1993. tab
Artículo en Portugués | LILACS | ID: lil-140118

RESUMEN

Sao descritos os achados clinico-laboratoriais da infeccao acidental pelo virus SP H 114202 (Arenavirus, familia Arenaviridae), um virus novo causador de febre hemorragica humana. O paciente, tecnico de laboratorio, apresentou quadro febril por 13 dias. A doenca cursou com febre elevada (39ºC) diaria, cefaleia, calefrios e mialgias por 8 dias. A partir do 3§ dia surgiram nauseas, vomitos alimentares e anorexia e no 10§ dia, epigastralgia, diarreia e gengivorragia....


Asunto(s)
Humanos , Masculino , Arenaviridae/patogenicidad , Infección de Laboratorio/diagnóstico , Arenaviridae/aislamiento & purificación , Ensayo de Inmunoadsorción Enzimática , Infección de Laboratorio/inmunología , Pruebas de Fijación del Complemento/métodos
6.
Zentralbl Bakteriol ; 279(4): 512-7, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8305808

RESUMEN

A case of laboratory-acquired infection with Escherichia coli O157:H7 is presented. Evidence of the identity of the infecting strain was provided by toxin type and plasmid profiles. Because no obvious technical errors in laboratory practices could be demonstrated we conclude that the infecting dose for E. coli O157:H7 may be small. The clinical course was uncomplicated; during reconvalescence, the patient's serum recognized a unique 87 kDa band on immunoblots of the infecting strain.


Asunto(s)
Infecciones por Escherichia coli/microbiología , Escherichia coli/patogenicidad , Infección de Laboratorio/microbiología , Anticuerpos Antibacterianos/sangre , Proteínas Bacterianas/inmunología , Toxinas Bacterianas/inmunología , Western Blotting , Niño , Colitis/microbiología , Ensayo de Inmunoadsorción Enzimática , Escherichia coli/inmunología , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/inmunología , Femenino , Hemorragia Gastrointestinal/microbiología , Humanos , Infección de Laboratorio/inmunología , Masculino , Persona de Mediana Edad , Toxina Shiga I , Toxina Shiga II
7.
MMWR Morb Mortal Wkly Rep ; 41(36): 678-81, 1992 Sep 11.
Artículo en Inglés | MEDLINE | ID: mdl-1513304

RESUMEN

Simian immunodeficiency viruses (SIVs) are lentiviruses that cause acquired immunodeficiency syndrome (AIDS)-like illnesses in susceptible macaque monkeys and are used in the study of AIDS (1). In November 1988, CDC published guidelines to minimize the risk of SIV transmission to research laboratory workers (2). This report summarizes the investigation of two laboratory workers who seroconverted following occupational exposures to SIV.


Asunto(s)
Infección de Laboratorio/inmunología , Macaca/microbiología , Personal de Laboratorio Clínico , Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología , Virus de la Inmunodeficiencia de los Simios/inmunología , Animales , Anticuerpos Antivirales/análisis , Humanos , Infección de Laboratorio/microbiología , Síndrome de Inmunodeficiencia Adquirida del Simio/transmisión
9.
JAMA ; 267(10): 1349-53, 1992 Mar 11.
Artículo en Inglés | MEDLINE | ID: mdl-1740856

RESUMEN

OBJECTIVE: After an employee at a cancer research institute was diagnosed with lymphocytic choriomeningitis, an investigation was performed to determine the extent of lymphocytic choriomeningitis virus (LCMV) infections among the institute's employees and to identify risk factors for infection. DESIGN: Retrospective cohort study. SETTING: A US cancer research institute. PARTICIPANTS: Eighty-two of 90 institute employees. MAIN OUTCOME MEASURES: Serum LCMV antibodies. RESULTS: Seven workers (9%) with definite LCMV infection (LCMV IgG antibody titer greater than or equal to 16) and one worker (1%) with probable infection (IgG titer = 8) were identified (10% overall seroprevalence). All infected employees handled animals or animal tissues and were more likely than other animal handlers to have worked with nude mice (Mus musculus) (P less than .02). Among the 31 employees who worked with nude mice at the institute, infected workers were more likely to clean the cages of nude mice (P much less than .001), change their bedding (P less than .01), and change their water (P less than .001). The institute had been injecting nude mice with LCMV-infected tumor cell lines and had recently increased the nude mouse population and the duration of experiments. These changes would have increased the LCMV burden at the facility and were temporally associated with the cluster of LCMV infections in employees. CONCLUSIONS: This LCMV outbreak, the first reported since 1974, is the first associated with nude mice. It illustrates the ongoing hazard LCMV poses in research laboratories. Since the symptoms of LCMV infection can be nonspecific, clinicians should consider this diagnosis in ill patients who report laboratory rodent exposure.


Asunto(s)
Brotes de Enfermedades , Infección de Laboratorio/epidemiología , Coriomeningitis Linfocítica/epidemiología , Ratones Desnudos/microbiología , Adulto , Animales , Anticuerpos Antivirales/análisis , Femenino , Humanos , Infección de Laboratorio/inmunología , Infección de Laboratorio/microbiología , Coriomeningitis Linfocítica/microbiología , Virus de la Coriomeningitis Linfocítica/inmunología , Masculino , Ratones , Ratones Desnudos/inmunología , Enfermedades de los Roedores/inmunología , Enfermedades de los Roedores/microbiología , Enfermedades de los Roedores/transmisión
10.
CMAJ ; 143(11): 1203-6, 1990 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-2171742

RESUMEN

Herpesvirus simiae (B virus) causes a mild infection in macaques. Transmission to humans may result in life-threatening encephalomyelitis. To evaluate the risk of occupational exposure to B virus we surveyed the directors of 11 biomedical laboratories in Quebec that use monkeys. Information was obtained on the monkey population and on the use of infection control measures recommended by the US Centers for Disease Control (CDC), Atlanta. Of the 519 monkeys belonging to susceptible species the serologic status was positive in 264 (51%), all captured in the wilds, and it was unknown in 24 (5%). All of the monkeys were caged individually, and newly acquired ones were quarantined for 2 to 8 weeks. Of the 84 workers 52 (62%) handled monkeys whose serologic status was either positive or unknown. Only five laboratories (representing 61% of the workers) complied fully with the CDC guidelines. Nine of the laboratories had a wound management protocol, but only six had a designated specialist for consultation and prophylaxis. Although no cases of B virus infection have been reported from Quebec the severity of human illness necessitates strict adherence to infection control measures and expert management of occupational exposure to susceptible monkeys.


Asunto(s)
Infecciones por Herpesviridae , Herpesvirus Cercopitecino 1 , Infección de Laboratorio , Macaca , Enfermedades de los Monos , Exposición Profesional , Animales , Anticuerpos Antivirales/análisis , Infecciones por Herpesviridae/inmunología , Infecciones por Herpesviridae/prevención & control , Infecciones por Herpesviridae/veterinaria , Herpesvirus Cercopitecino 1/inmunología , Humanos , Infección de Laboratorio/inmunología , Infección de Laboratorio/prevención & control , Macaca/inmunología , Enfermedades de los Monos/inmunología , Quebec , Riesgo
13.
Pol Tyg Lek ; 44(17): 383-6, 1989 Apr 24.
Artículo en Polaco | MEDLINE | ID: mdl-2626358

RESUMEN

The study aimed at answering the question whether markers of the viral hepatitis, namely HBs antigen and anti-HBs antibodies, are significantly more frequent in the personnel of the analytical laboratories than in blood donors of the City Blood Donation Centre. Together 1,284 persons employed at 88 analytical laboratories were examined. These persons were divided into the groups according to the occupation, age and duration of the employment. HBs antigen was detected with EIA technique in 13 subjects making 1,025% of all examined individuals whereas anti-HBs antibodies were detected with EIP technique in 20 subjects, i.e. 1,560%. Detectability of HBs antigen and anti-HBS antibodies in blood donors was 0.443% and 0.04% respectively. The obtained results indicate significantly more frequent occurrence of both markers in the employees of the analytical laboratories.


Asunto(s)
Portador Sano/inmunología , Anticuerpos contra la Hepatitis B/análisis , Antígenos de Superficie de la Hepatitis B/análisis , Hepatitis B/inmunología , Infección de Laboratorio/inmunología , Enfermedades Profesionales/inmunología , Adulto , Portador Sano/epidemiología , Hepatitis B/epidemiología , Anticuerpos contra la Hepatitis B/inmunología , Antígenos de Superficie de la Hepatitis B/inmunología , Humanos , Infección de Laboratorio/epidemiología , Persona de Mediana Edad , Enfermedades Profesionales/epidemiología , Polonia , Población Urbana
14.
Zentralbl Bakteriol Mikrobiol Hyg A ; 270(4): 534-41, 1989 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2652951

RESUMEN

Two symptomatic Toxoplasma infections of laboratory personnel have been serologically followed up for 5.5 and 10 months, respectively. Results obtained by commonly used test systems (indirect fluorescent antibody tests for IgG and IgM antibodies, complement fixation test) were compared with those of two recently developed and improved tests for IgM detection (immunosorbent agglutination assay [ISAGA] and solid-phase indirect haemadsorption assay [SPIHA] as well as with those of a test designed for the detection of circulating antigen (cag-ELISA).


Asunto(s)
Antígenos de Protozoos/análisis , Inmunoglobulina M/análisis , Infección de Laboratorio/inmunología , Toxoplasma/inmunología , Toxoplasmosis/inmunología , Adulto , Pruebas de Aglutinación , Animales , Anticuerpos Antiprotozoarios/análisis , Anticuerpos Antiprotozoarios/biosíntesis , Pruebas de Fijación del Complemento , Ensayo de Inmunoadsorción Enzimática , Femenino , Técnica del Anticuerpo Fluorescente , Hemabsorción , Humanos , Inmunoglobulina G/análisis , Técnicas de Inmunoadsorción , Infección de Laboratorio/diagnóstico , Toxoplasmosis/diagnóstico
15.
Am J Med Sci ; 293(5): 293-7, 1987 May.
Artículo en Inglés | MEDLINE | ID: mdl-3109240

RESUMEN

The authors studied the antigenicity of intradermal human diploid cell rabies vaccine administered to 40 laboratory workers considered to be at-risk at the University of Virginia Medical Center. A 1-year postvaccination serology was determined for 20 of those 40, all of whom demonstrated an antirabies titer greater than or equal to 1:50 by the raped fluorescent focus inhibition test. By 2 years' postvaccination, 5 of 40 subjects had "unprotective levels" (less than 1:5), whereas 35 had titers greater than or equal to 1:5, and none had a titer greater than or equal to 1:50. Booster doses given to four subjects whose titers had declined produced a 1-month postvaccination antirabies titer greater than or equal to 1:50 in all cases. Vaccine administration by the intradermal rather than the intramuscular route resulted in a cost savings of $120 (U.S.) per employee. This data indicate that the intradermal administration of human diploid cell vaccine for rabies pre-exposure prophylaxis achieves an immunologic response thought to be protective while providing a substantial cost savings when compared with the intramuscular route of administration. Those who receive primary pre-exposure rabies vaccination should have serologic confirmation of immunologic protection every 2 years with a booster dose given to subjects demonstrating a titer less than 1:5.


Asunto(s)
Vacunas Antirrábicas/administración & dosificación , Rabia/prevención & control , Vacunación/economía , Adolescente , Anticuerpos Antivirales/análisis , Análisis Costo-Beneficio , Femenino , Humanos , Esquemas de Inmunización , Inmunización Secundaria/economía , Inyecciones Intradérmicas , Infección de Laboratorio/inmunología , Infección de Laboratorio/prevención & control , Masculino , Rabia/inmunología , Virus de la Rabia/inmunología , Vacunación/métodos
17.
Biken J ; 25(4): 163-70, 1982 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6307255

RESUMEN

One of the authors (Y.O.), who had previously been immunized with Japanese encephalitis (JE) vaccine, showed symptoms of typical dengue fever 6 days after accidental infection with a newly isolated dengue type 4 virus strain from a patient with dengue hemorrhagic fever (DHF) in Thailand. His sera were examined by hemagglutination inhibition (HI), complement fixation (CF) and neutralization (N) tests. The JE N antibody titers of his sera were high even on the first day of the illness and remained almost constant during the next year. Antibodies that reacted with dengue viruses were detected from a very early stage of the illness by all three serological tests. In addition, his convalescent phase sera showed high titers against all 4 types of dengue virus. These data suggest that the dengue infection caused secondary stimulation of antigens of flavivirus. Sedimentation analysis of antibodies in Y.O.'s serum (day 9) was carried out and IgM antibody that reacted only with dengue type 4 virus and homologous infecting virus was separated. These findings clearly demonstrated that the laboratory infection of Y.O. was primary dengue infection with dengue type 4 virus.


Asunto(s)
Dengue/inmunología , Infección de Laboratorio/inmunología , Anticuerpos Antivirales/análisis , Centrifugación por Gradiente de Densidad , Pruebas de Fijación del Complemento , Encefalitis Japonesa/inmunología , Pruebas de Inhibición de Hemaglutinación , Humanos , Masculino , Pruebas de Neutralización
18.
Am J Trop Med Hyg ; 30(4): 855-61, 1981 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7196163

RESUMEN

Laboratory-acquired infections encountered between 1963 and 1977 among personnel of the Virus Research Laboratory, Ibadan, Nigeria, are reported. Two cases of chikungunya infection occurred and one each with Dugbe, Wesselsbron, and dengue viruses. In each case, virus was isolated or development of antibody demonstrated. Among virus and two each to chikungunya and Rift Valley fever viruses, without experiencing any clinically recognized disease.


Asunto(s)
Infecciones por Arbovirus/epidemiología , Infección de Laboratorio/epidemiología , Adulto , Animales , Anticuerpos Antivirales/inmunología , Infecciones por Arbovirus/etiología , Infecciones por Arbovirus/inmunología , Virus Chikungunya , Pruebas de Fijación del Complemento , Dengue/epidemiología , Humanos , Infección de Laboratorio/inmunología , Masculino , Nigeria , Fiebre del Valle del Rift/epidemiología , Ensayo de Placa Viral
19.
J Clin Microbiol ; 12(3): 343-50, 1980 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6783677

RESUMEN

A microplate enzyme-linked immunosorbent assay (ELISA), developed for the detection of antibodies to typhus group rickettsiae, was used to analyze human sera from individuals engaged directly or indirectly in rickettsial research. The earliest serum available from each of 112 individuals was tested for immunoglobulin M (IgM) and IgG antibodies against Rickettsia typhi and Rickettsia prowazekii by ELISA at a 1:500 dilution. In at least one assay, nine sera had ELISA optical densities of greater than 0.2, which were above the mean optical densities plus three standard deviations of the other 103 sera. Three of the positive sera were from individuals with known clinical cases of typhus infection. The other sera with predominantly IgG titers were from individuals with extended laboratory exposure to rickettsiae or histories of typhus vaccination, or both. During continued serological surveillance, eight additional people with repeated occupational exposure to typhus rickettsiae had seroconversions in the ELISA to optical densities of greater than 0.2. No apparent clinical illness occurred in two individuals, whereas six clinical cases of infection occurred in others subsequent to accidental laboratory autoinoculation (one) or aerosol exposures (five). In the clinical infections, antibodies were first detected at 7 days, but in subsequent sera, rises and declines in titers were quite variable and were influenced by vaccination, relapse, and time and extent of antibiotic therapy. In primary infections the sera of several individuals who received immediate antibiotic therapy had brief strong IgM responses without pronounced increases in IgG. In contrast, much higher IgG levels were attained in three cases in which relapse occurred, the individual had previously been immunized, or treatment had been delayed. The microplate ELISA proved to be a highly sensitive and reliable test for detection of the human serological response to typhus antigens.


Asunto(s)
Anticuerpos Antibacterianos/análisis , Ensayo de Inmunoadsorción Enzimática , Técnicas para Inmunoenzimas , Infección de Laboratorio/inmunología , Rickettsia prowazekii/inmunología , Rickettsia typhi/inmunología , Infecciones por Rickettsiaceae/inmunología , Antibacterianos/farmacología , Anticuerpos Antibacterianos/biosíntesis , Técnica del Anticuerpo Fluorescente , Humanos , Inmunoglobulina G/análisis , Inmunoglobulina M/análisis , Recurrencia , Estudios Retrospectivos , Vacunación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...